1. How to submit my research paper? What’s the process of publication of my paper?
The journal receives submitted manuscripts via email only. Please submit your research paper in .doc or.pdf format to the submission email: ijpmbs@ejournal.net.
You’ll be given a paper number if your submission is successful. Your paper then will undergo peer review process, which may take approximately one and a half months under normal circumstances, three tops.
After blind peer review, you will receive the notification letter with the review result of your paper...
2. Can I submit an abstract?
The journal publishes full research papers.[Read More]

A Review Article on the Basic Concepts of Drug Delivery Systems as Targeting Agents

Heba S. Elsewedy 1,2, Bandar E. Al Dhubiab 2, Mahmoud A Mahdy 1, and Hanan M Elnahas 1,
1. Department of Pharmaceutics, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt
2. Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Saudi Arabia

Abstract—Cancer represents the most life threatening disease worldwide where cells lose their normal regulatory mechanism that control their growth hence cells grow out of control resulting in a mass known as tumor. It shows complicated protocols of treatment, as the major limitation of most conventional anticancer therapy is the lack of tumor selectivity and killing of both normal and abnormal cells. Recently, several interests were introduced in the field of Drug Delivery Systems (DDS) in order to enhance the therapeutic effect and decrease the side effects of anticancer drugs. Several mechanisms have been introduced to moderate the effect of DDS, among them passive drug targeting, where the drug is incorporated into surface modified nanocarriers such as liposomes, niosomes, solid lipid Nanoparticles (NP) and Nanoemulsions (NE). Surface modification is achieved by increasing the hydrophilicity of the DDS since, it is known that hydrophobic surfaces tends to absorb high amount of proteins. Among hydrophilic polymer, PEG, PVA, dextran. However, PEG is the most frequently hydrophilic polymer applied for surface modification that increase the circulation time of nanocarriers and reduce the liver uptake compared to non-surface modified one. The Enhanced Permeability and Retention (EPR) effect is a phenomenon of tumor cells related to their anatomical and pathophysiological structure and their variations from normal tissues. EPR effect provides long-circulating PEG nanocarriers with a high opportunity to target tumor cells following systemic administration. In the current review a brief summary regarding nanocarriers and its mechanism as a drug targeting systems are discussed.

Index Term—drug targeting, anticancer, nanocarriers, PEGylation

Cite:Heba S. Elsewedy, Bandar E. Al Dhubiab, Mahmoud A Mahdy, and Hanan M Elnahas, "A Review Article on the Basic Concepts of Drug Delivery Systems as Targeting Agents," International Journal of Pharma Medicine and Biological Sciences, Vol. 10, No. 1, pp. 23-29, January 2021. doi: 10.18178/ijpmbs.10.1.23-29

Copyright © 2021 by the authors. This is an open access article distributed under the Creative Commons Attribution License (CC BY-NC-ND 4.0), which permits use, distribution and reproduction in any medium, provided that the article is properly cited, the use is non-commercial and no modifications or adaptations are made.
Copyright © 2012-2024 International Journal of Pharma Medicine and Biological Sciences, All Rights Reserved
E-mail: ijpmbs@ejournal.net